Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added Kharkiv Oblast and Kharkiv, Ukraine (61024) to the locations. Removed Kharkivs’ka Oblast’ and the corresponding Ukrainian entry.
    Difference
    0.0%
    Check dated 2026-05-30T12:21:31.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays a new revision tag: v3.5.4, replacing the previous v3.5.3. This indicates an update to the site’s build or content framework rather than any change to the study details.
    Difference
    0.0%
    Check dated 2026-05-15T23:51:43.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The study record now shows a completed status with updated timestamps marking the end of the trial's lifecycle; the former recruiting indicator and associated dates were removed to reflect that recruitment is finished and results may be posted.
    Difference
    0.1%
    Check dated 2026-05-08T23:12:03.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 333 was replaced with Taoyuan, Taiwan, 333 in the locations list, updating the Taiwan study site address to reflect the correct city designation. This refines the site data to help participants identify and navigate to the correct study location.
    Difference
    0.0%
    Check dated 2026-05-01T20:18:58.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The study’s listed site locations were updated by switching between region-name variants (Spanish/Czech administrative region wording) and adding the simplified versions for certain Chile and Czechia entries. Separately, the page revision/version string was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.3%
    Check dated 2026-04-24T16:45:52.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2. This appears to be a minor software version update with no visible changes to the study details.
    Difference
    0.0%
    Check dated 2026-04-17T13:36:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.